Left ventricular hypertrophy amplifies the QT, and Tp-e intervals and the Tp-e/QT ratio of left chest ECG

Journal of Biomedical Research

Volumn 24, Issue 1, 2010, Pages 69-72

  Zhao, Zhao ^a   Yuan, Zuyi ^a   Ji, Yuqiang ^a   Wu, Yue ^a   Qi, Yinzhi ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Arrhythmia; Hypertension; Left ventricular hypertrophy; QT interval; Tp e interval

Indexed keywords

ADULT; AGED; ARTICLE; BODY SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY MONITORING; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART RATE; HEART REPOLARIZATION; HUMAN; HYPERTENSION; LONG QT SYNDROME; MALE; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; T WAVE; THORAX; TP E INTERVAL;

EID: 78449286025     PISSN: 16748301     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1674-8301(10)60011-5     Document Type: Article

References (22)

1. de Simone G, Gottdiener JS, Chinali M, Maurer MS Left ventricular mass predicts heart failure not related to previous myocardial infarction: the Cardiovascular Health Study. Eur Heart J 2008, 29:741-747.
2. Gerdts E, Okin PM, de Simone G, Cramariuc D, Wachtell K, Boman K, et al. Gender differences in left ventricular structure and function during antihypertensive treatment. The Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension 2008, 51:1109-1114.
3. Luo X, Lin H, Pan Z, Xiao J, Zhang Y, Lu Y, et al. Down-regulation of miR-1/miR-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart. J Biol Chem 2008, 283:20045-20052.
4. Marionneau C, Brunet S, Flagg TP, Pilgram TK, Demolombe S, Nerbonne JM Distinct cellular and molecular mechanisms underlie functional remodeling of repolarizing K+ currents with left ventricular hypertrophy. Circ Res 2008, 102:1406-1415.
5. Wang JF, Shan QJ, Yang B, Chen ML, Zou JG, Xu DJ, et al. Tpeak-Tend interval as a new risk factor for arrhythmic event in patient with Brugada syndrome. JNMU 2007, 21:213-217.
6. Yan GX, Antzelevitch C Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome. Circulation 1998, 98:1928-1936.
7. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003, 289:2560-2572.
8. Sun NL Hypertension and heart failure. Chin J Cardiol(in chinese) 2004, 32:382-384.
9. Edwards NC, Steeds RP, Stewart PM, Ferro CJ, Townend JN Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: a randomized controlled trial. J Am Coll Cardiol 2009, 54:505-512.
10. Bazett HC An analysis of the time-relations of electrocardiograms. Ann Noninvasive Electrocardiol 2006, 2:177-194.
11. Guo D, Young L, Patel C, Jiao Z, Wu Y, Liu T, et al. Calcium-activated chloride current contributes to action potential alternations in left ventricular hypertrophy rabbit. Am J Physiol Heart Circ Physiol 2008, 295:H97-104.
12. Salles GF, Cardoso CR, Leocadio SM, Muxfeldt ES Recent ventricular repolarization markers in resistant hypertension: are they different from the traditional QT interval?. Am J Hypertens 2008, 21:47-53.
13. Hlaing T, Guo D, Zhao X, DiMino T, Greenspon L, Kowey PR, et al. The QT and Tp-e intervals in left and right chest leads: comparison between patients with systemic and pulmonary hypertension. J Electrocardiol 2005, 38(Suppl 4):S154-S158.
14. Gupta P, Patel C, Patel H, Narayanaswamy S, Malhotra B, Green JT, et al. Tp-e/QT ratio as an index of arrhythmogenesis. J Electrocardiol 2008, 41:567-574.
15. Billman GE, Kukielka M Novel transient outward and ultra-rapid delayed rectifier current antagonist, AVE0118, protects against ventricular fibrillation induced by myocardial ischemia. J Cardiovasc Pharmacol 2008, 514:352-358.
16. Saenen JB, Vrints CJ Molecular aspects of the congenital and acquired Long QT Syndrome: clinical implications. J Mol Cell Cardiol 2008, 44:633-646.
17. Wang D, Patel C, Cui C, Yan GX Preclinical assessment of drug-induced proarrhythmias: role of the arterially perfused rabbit left ventricular wedge preparation. Pharmacol The 2008, 119:141-151.
18. Liu T, Brown BS, Wu Y, Antzelevitch C, Kowey PR, Yan GX Blinded validation of the isolated arterially perfused rabbit ventricular wedge in preclinical assessment of drug-induced proarrhythmias. Heart Rhythm 2006, 3:948-956.
19. Yamaguchi M, Shimizu M, Ino H, Terai H, Uchiyama K, Oe K, et al. T wave peak-to-end interval and QT dispersion in acquired long QT syndrome: a new index for arrhythmogenicity. Clin Sci (Lond) 2003, 105:671-676.
20. Zhao X, Qu L, Peng Z, Li L, Cui C The difference between QT and T(p-e) intervals in left and right chest leads in patients with hypertension and chronic obstructive pulmonary diseases. Chin J Cardiac Pacing Electrophysiol(in chinese) 2009, 23:116-118.
21. Letsas KP, Efremidis M, Kounas SP, Pappas LK, Gavrielatos G, Alexanian IP, et al. Clinical characteristics of patients with drug-induced QT interval prolongation and torsade de pointes: identification of risk factors. Clin Res Cardiol 2009, 98:208-212.
22. Sabir IN, Killeen MJ, Goddard CA, Thomas G, Gray S, Grace AA, et al. Transient alterations in transmural repolarization gradients and arrhythmogenicity in hypokalaemic Langendorff-perfused murine hearts. J Physiol 2007, 581:277-289.